Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 13;4(1):00163-2017.
doi: 10.1183/23120541.00163-2017. eCollection 2018 Jan.

Research highlights from the 2017 ERS International Congress: airway diseases in focus

Cecilia Andersson  1 , Sara J Bonvini  1 , Peter Horvath  2 , Eduardo Marquez  3   4 , Imran Satia  5 , Paul Kirkham  6 , Florence Schleich  7 , Marco Idzko  8 , Reinoud Gosens  9 , Jose Luis Lopez-Campos  4 , Apostolos Bossios  10   11   12 , Omar Usmani  1 , Antonio Spanevello  13 , Ian M Adcock  1 , Alexander G Mathioudakis  5
Affiliations
Review

Research highlights from the 2017 ERS International Congress: airway diseases in focus

Cecilia Andersson et al. ERJ Open Res. .

Abstract

For another year, high-quality research studies from around the world transformed the annual ERS International Congress into a vivid platform to discuss trending research topics, to produce new research questions and to further push the boundaries of respiratory medicine and science. This article reviews only some of the high-quality research studies on asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and chronic cough that were presented during the congress through the Airway Diseases Assembly (ERS Assembly 5) and places them into the context of current knowledge and research challenges.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: R. Gosens reports receiving grants from Chiesi Farmaceutici, Boehringer Ingelheim and Aquilo BV, outside the submitted work. I. Satia reports receiving a BMA James Trust Award, personal fees from educational talks for general practitioners, travel awards and an ERS Respire 3 Fellowship Award, outside the submitted work. O. Usmani reports receiving personal fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, NAPP, Mundipharma, Sandoz, Cipla, Takeda, Zentiva and Trudell Medical, and grants from AstraZeneca, Boehringer Ingelheim, Chiesi, Prosonix, Edmond Pharma, Cipla, NAPP, Mundipharma, Sandoz and Aerocrine, outside the submitted work.

References

    1. Pavord ID, Bush A, Holgate S. Asthma diagnosis: addressing the challenges. Lancet Respir Med 2015; 3: 339–341. - PubMed
    1. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368: 804–813. - PubMed
    1. Accordini S, Corsico AG, Braggion M, et al. The cost of persistent asthma in Europe: an international population-based study in adults. Int Arch Allergy Immunol 2013; 160: 93–101. - PubMed
    1. Koczulla AR, Vogelmeier CF, Garn H, et al. New concepts in asthma: clinical phenotypes and pathophysiological mechanisms. Drug Discov Today 2017; 22: 388–396. - PubMed
    1. Chung KF, Adcock IM. How variability in clinical phenotypes should guide research into disease mechanisms in asthma. Ann Am Thorac Soc 2013; 10: Suppl., S109–S117. - PMC - PubMed